# Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

> **NCT05204784** · NA · UNKNOWN · sponsor: **Peter Korsten** · enrollment: 30 (estimated)

## Conditions studied

- Systemic Sclerosis
- Raynaud Phenomenon
- Digital Ulcer
- Scleroderma

## Interventions

- **PROCEDURE:** Rheopheresis treatment
- **DRUG:** Intravenous Infusion

## Key facts

- **NCT ID:** NCT05204784
- **Lead sponsor:** Peter Korsten
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-28
- **Primary completion:** 2023-12
- **Final completion:** 2024-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05204784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05204784, "Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05204784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*